July 20, 2023

BioPharmGuyNews.png

Purchase Data

Promoted Listings

Aligning drug and partnering strategies for small molecule API success

Ensuring your small molecule API successfully reaches patients means scrutinizing your potential partners’ depth of services, scientific mastery and overall capacity.


To help you streamline this process, we’ve produced a white paper that offers some practical advice on how to align your drug development strategy with the expertise of an altogether different CDMO partner to achieve small molecule API success.


Download the white paper > 

BioPharmGuy

This week, I was informed by a client that they submitted a data quote request and never heard back. Hearing something like that makes my heart stop as President of a web-based business.


Upon looking into it, none of the submission forms had been working since July 1. (head droops into hands) We will be fixing this shortly.


If you ever send a message and it involves the possibility of paying us for something, rest assured we will respond. If you don't hear anything, something is amiss so feel free to reach out to me on Linkedin. I do check those messages.


-BPG


Companies Added & Removed

Small number of edits this week. Back next week with a double summary.

Industry

Team Roast - Biker

Did she show up to work in her worst outfit not knowing it was picture day?


Did the photographer forget about her until she was walking out at 5:30?


There simply has be a rational explanation for wearing a leather jacket in a head shot.


Team Roast - Bikers

Then there's the team at Neogene who seems to have been gifted matching bike shirts. They duly hopped on their wheels and put a picture of the crew atop the Team page.


This picture reminds us how biking is the anti-yoga in that one cannot possibly look good in biking attire, no matter what.


Ohh Noo

Juvenile. That’s all this company is. The company name is Ohh-Med and they sell an at-home ED device called Vertica. The press release reads like satire. They talk of 'satisfied customers' visit their offices to 'express their gratitude'.


We’re sure they do! 


Joking aside, you have to give them some credit for the ballsy icon choice on this chart.


Leverage

It's common for people who have no idea what they're talking about to pepper in a 'leverage' now and again. Usually when people say leverage, they just mean 'use'. But only a person who wanted to look dumb would say it that way!


Here we have a cell therapy company who says they are leveraging cells to make people look younger and feel better. To hammer it home, they put together a piano-backed, poorly animated video to deeply explain their technology. Just kidding, they put some words on there and some random pictures.


Shockingly, they're publicly traded. All these public companies in the promotional business with nothing to sell are quite confounding. Ok they're not, they're just hoping to lure in some more suckers.


Holiday in Houston

In an ongoing story, there still seem to be 1000+ macaques hanging around in Texas because Charles River imported them from Cambodia and they were likely taken from the wild, which is an international no-no. 


The question is what to do with them. One estimate for housing them permanently ran to $125 million (which is obviously a joke - these things don't even have a cellphone plan!) The feds were entertaining the idea of sending them back home, but PETA had a problem with that, because they have a problem with everything.


As of now they are living their best life in a Houston warehouse, much like those Christmas pajamas you ordered last year from Amazon.


American Scheme

When announcing your plan to move the company headquarters from Australia to the United States, there may be better ways to refer to it than as a collection of schemes.


But also, if you're operating a weed/psychedelic company, accidental honesty can be refreshing.


AIS Biotech

This company launched with the goal of fighting the flu with carbohydrates.


Dudes! Gatorade beat you to it by about 35 years.


Biotech Killers

We mentioned Crossbow Therapeutics last week, which was a nice addition to our BioPharmory.


They join Arrowhead Pharmaceuticals, Dart NeuroScience & Slingshot Biosciences.


We also have Castle Biosciences & Moat Biotechnology who teamed up to repel Marauder Therapeutics (which duly changed its name to CAMP4 Therapeutics).


A violent group here.


Website Roast - A New Era

If it weren't for a recent date shown by a homepage news item, we would have thought this website was a relic from an earlier time. But no, it's active, and it is glorious.


Seven-month-old livestream as the lead item? Correct!

Screenshots from Fox News at the ready? Check!

News item from seven years ago still on the homepage? Yes!

Mobile unfriendly layout? No doubt!


Look out 2007, Nanoviricides is ready for ya!

Health & Science

Birth Control goes OTC

This time last week, FDA approved the first over-the-counter birth control pill. This is a watershed moment for women's contraceptive rights, and will no doubt come in handy for the many millions who live in states where condom failure means a lifetime of unwanted parenthood.


As of now it is expected to become available in early 2024, though stay tuned 'til next week when some backwards state tries to ban it. Because it's never been about rights - it's always been about control.

Promote Your Listing at BioPharmGuy

Check your website's analytics - BioPharmGuy is likely your top referrer.


Bump up those referrals even more with a Premium Listing. Learn more - Promoted Listings.

Subscribe!

If you're reading this and not a subscriber, please join our mailing list.

BioPharmGuy is a registered trademark of Wilsonian LLC, Content © 2023 Wilsonian LLC